ARTICLE | Company News
GSK, BAYG in ED co-promotion deal
November 15, 2001 8:00 AM UTC
GlaxoSmithKline (GSK; LSE:GSK) and Bayer (FSE:BAYG) will co-promote worldwide outside Japan BAYG's vardenafil oral selective phosphodiesterase-5 ( PDE5) inhibitor that is under FDA review to treat ere...